Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Assistenzarzt/-ärztin, Klinik für Allgemein-, Viszeral- und Transplantationschirugie
Aktuelle Veranstaltungen
-
WiSe 2025
- Endokrinologisch-nuklearmedizinisch-chirurgisches Kolloquium (*)
- Integriertes Seminar klinische Untersuchungen (1. Abschnitt der Ärztlichen Ausbildung) (nur Wintersemester) (PV)
- Chirurgie Blockpraktikum (PV)
- Klinischer Untersuchungskurs (1. Semester des zweiten Abschnittes) (PV)
- Endokrines Tumorzentrum am WTZ und ENETS-Center of Excellence
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
- Integriertes Seminar klinische Untersuchungen (1. Abschnitt der Ärztlichen Ausbildung) (nur Wintersemester) (PV)
- Endokrinologisch-nuklearmedizinisch-chirurgisches Kolloquium (*)
- Chirurgie Blockpraktikum (PV)
- Klinischer Untersuchungskurs (1. Semester des zweiten Abschnittes) (PV)
- Endokrines Tumorzentrum am WTZ und ENETS-Center of Excellence
-
SoSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Comprehensive Assessment of Multikinase Inhibitor Therapy Outcomes in RAIR-(P)DTC and MTC at a Tertiary Referral CenterIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), 2025, in press
-
Corrigendum: The highly and perpetually upregulated thyroglobulin gene is a hallmark of functional thyrocytesIn: Frontiers in Cell and Developmental Biology, Jg. 13, 2025, 1571466DOI (Open Access)
-
Dissection of RET p.M918T-driven progression of hereditary vs. sporadic medullary thyroid cancerIn: European Journal of Surgical Oncology, Jg. 51, 2025, Nr. 3, 109549
-
Geospatial inheritance across the breath of the RET mutational landscape of multiple endocrine neoplasia 2AIn: Endocrine, Jg. 90, 2025, Nr. 2, S. 1027 – 1034
-
Hormonsyndrome bei neuroendokrinen Tumoren : Richtig diagnostizieren und behandelnIn: Die Gastroenterologie, 2025, in press
-
Incidence and distribution of neck node metastases in hereditary vs. sporadic medullary thyroid cancer at basal calcitonin serum levels ≤100 pg/ml : 30-year experienceIn: European Journal of Surgical Oncology, Jg. 51, 2025, Nr. 7, 109756
-
Lenvatinib as salvage therapy in advanced and progressive GI-NETIn: Endocrine-Related Cancer, Jg. 32, 2025, Nr. 8, e250165
-
30 Jahre prophylaktische Thyreoidektomie beim hereditären medullären Schilddrüsenkarzinom : Ein Meilenstein translationaler MedizinIn: Die Chirurgie, Jg. 95, 2024, Nr. 8, S. 638 – 650DOI (Open Access)
-
Anatomical Patterns of Nodal Spread in Unilateral Papillary and Medullary Thyroid CancerIn: Thyroid, Jg. 34, 2024, Nr. 7, S. 871 – 879
-
Axillary Node Metastases of Medullary Thyroid Cancer : A Hallmark of Terminal DiseaseIn: Hormone and Metabolic Research, Jg. 56, 2024, Nr. 6, S. 429 – 434DOI (Open Access)
-
Genotype-specific development of MEN 2 constituent components in 683 RET carriersIn: Endocrine-Related Cancer, Jg. 31, 2024, Nr. 7, e240038
-
Hormonal Hypersecretion and Pain : Rare But Not To Be ForgottenIn: The American Journal of Medicine, Jg. 137, 2024, Nr. 4, S. 311 – 314
-
Oncological features of sporadic vs. hereditary pediatric medullary thyroid cancerIn: Endocrine, Jg. 85, 2024, Nr. 3, S. 1091 – 1095
-
Origin and impact of multifocal growth in sporadic vs. hereditary medullary thyroid cancerIn: European Journal of Surgical Oncology, Jg. 50, 2024, Nr. 11, 108625
-
Sexual dimorphism in medullary thyroid cancer aggressivenessIn: Endocrine-Related Cancer, Jg. 31, 2024, Nr. 3, e230301
-
The INMSG Survey on the Loss of Signal Management on the First Side During Planned Bilateral Thyroid SurgeryIn: Journal of Otolaryngology - Head & Neck Surgery, Jg. 53, 2024, 19160216241265684DOI (Open Access)
-
Clinical presentation of MEN 2A in index vs. non-index patientsIn: Endocrine, Jg. 82, 2023, Nr. 2, S. 450 – 455
-
Hemithyreoidektomie oder totale Thyreoidektomie beim papillären Niedrigrisikokarzinom der Schilddrüse? : Chirurgische Kriterien der primären und sekundären Therapiewahl im interdisziplinären BehandlungskonzeptIn: Die Chirurgie, Jg. 94, 2023, Nr. 1, S. 79 – 92
-
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid CarcinomaIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 12, S. 1865 – 1868DOI (Open Access)
-
Sporadic noninvasive medullary thyroid neoplasm : A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomyIn: Surgery, Jg. 174, 2023, Nr. 6, S. 1356 – 1362
-
The Changing Face of Multiple Endocrine Neoplasia 2A : From Symptom-Based to Preventative MedicineIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 108, 2023, Nr. 9, S. e734 – e742DOI (Open Access)
-
The highly and perpetually upregulated thyroglobulin gene is a hallmark of functional thyrocytesIn: Frontiers in Cell and Developmental Biology, Jg. 11, 2023, 1265407DOI (Open Access)
-
The internal mammary artery perforator flap for neck reconstruction after palliative resection of advanced anaplastic thyroid cancer : a case reportIn: Journal of Medical Case Reports, Jg. 17, 2023, Nr. 1, 8DOI, Online Volltext (Open Access)
-
Clinical Significance of Coexistence of Hashimoto Thyroiditis and Graves’ Disease with Differentiated and Medullary Thyroid CancerIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 130, 2022, Nr. 06, S. 381 – 385
-
Clonidine suppression test for a reliable diagnosis of pheochromocytoma : When to useIn: Clinical Endocrinology, Jg. 97, 2022, Nr. 5, S. 541 – 550DOI (Open Access)
-
Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with PheochromocytomaIn: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 6, S. 869 – 874DOI (Open Access)
-
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm StudyIn: Clinical Cancer Research, Jg. 28, 2022, Nr. 19, S. 4194 – 4202DOI (Open Access)
-
Medullary thyroid cancer and pheochromocytoma in MEN2A : Are there parent of origin effects on disease expression?In: Familial Cancer, Jg. 21, 2022, Nr. 4, S. 473 – 478
-
Recurrent ipsilateral pheochromocytoma in carriers of RET p.Cys634 missense mutationsIn: Endocrine, Jg. 77, 2022, Nr. 1, S. 160 – 167
-
Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid CancerIn: Hormone and Metabolic Research, Jg. 54, 2022, Nr. 1, S. 7 – 11DOI (Open Access)
-
Sex differences in MEN 2A penetrance and expression according to parental inheritanceIn: European Journal of Endocrinology (EJE), Jg. 186, 2022, Nr. 4, S. 469 – 476
-
Superiority of metastatic lymph node ratio over number of node metastases and TNM/AJCC N classification in predicting cancer-specific survival in medullary thyroid cancerIn: Head and Neck, Jg. 44, 2022, Nr. 12, S. 2717 – 2726
-
Temporal trends in referrals of RET gene carriers for neck surgery to a tertiary surgical center in the era of international management guidelinesIn: Endocrine, Jg. 80, 2022, Nr. 1, S. 100 – 110
-
Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extensionIn: BMC Endocrine Disorders, Jg. 21, 2021, Nr. 1, 161DOI, Online Volltext (Open Access)
-
Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma : Lessons From Individual Cases With Long-Term Follow-UpIn: Frontiers in Endocrinology, Jg. 12, 2021, 718418DOI, Online Volltext (Open Access)
-
Distinct Late-Night Salivary Cortisol Cut-Off Values for the Diagnosis of HypercortisolismIn: Hormone and Metabolic Research, Jg. 53, 2021, Nr. 10, S. 662 – 671DOI (Open Access)
-
Dll3 (Delta-like protein 3) expression correlates with stromal desmoplasia and lymph node metastases in medullary thyroid carcinomasIn: Endocrine Connections, Jg. 10, 2021, Nr. 3, S. 283 – 289DOI (Open Access)
-
Effect of High Dose Active Vitamin D Therapy on the Development of Hypocalcemia After Subtotal Parathyroidectomy in Patients on Chronic DialysisIn: International Journal of Nephrology and Renovascular Disease, Jg. 14, 2021, S. 399 – 410DOI (Open Access)
-
Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer : Lessons LearnedIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 106, 2021, Nr. 8, S. e2968 – e2979DOI (Open Access)
-
Informed Consent for Intraoperative Neural Monitoring in Thyroid and Parathyroid Surgery : Consensus Statement of the International Neural Monitoring Study GroupIn: Frontiers in Endocrinology, Jg. 12, 2021, 795281DOI (Open Access)
-
Lymph node metastasis in hereditary medullary thyroid cancer is independent of the underlying RET germline mutationIn: European Journal of Surgical Oncology, Jg. 47, 2021, Nr. 4, S. 920 – 923
-
Management of primary and renal hyperparathyroidism : Guidelines from the German Association of Endocrine Surgeons (CAEK)In: Langenbeck's Archives of Surgery, Jg. 406, 2021, S. 571 – 585
-
Metastatic Risk Profile of Microscopic Lymphatic and Venous Invasion in Medullary Thyroid CancerIn: Hormone and Metabolic Research, Jg. 53, 2021, Nr. 9, S. 588 – 593DOI (Open Access)
-
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTCIn: Cancers, Jg. 13, 2021, Nr. 7, S. 1728DOI, Online Volltext (Open Access)
-
Prophylactic neck surgery for second-generation multiple endocrine neoplasia type 2BIn: European Journal of Surgical Oncology, Jg. 47, 2021, Nr. 4, S. 924 – 927
-
Training Courses in Laryngeal Nerve Monitoring in Thyroid and Parathyroid Surgery- The INMSG Consensus StatementIn: Frontiers in Endocrinology, Jg. 12, 2021, 705346DOI (Open Access)
-
100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2AIn: Endocrine, Jg. 68, 2020, S. 368 – 376
-
Komplettierungsoperation nach nichttotaler Thyreoidektomie beim postoperativ diagnostizierten follikulären SchilddrüsenkarzinomIn: Der Chirurg, Jg. 91, 2020
-
Long-term outcome of surgical resection in patients with gastroenteropancreatic neuroendocrine neoplasia : results from a German nation-wide multi-centric registryIn: Langenbeck's Archives of Surgery, Jg. 405, 2020, Nr. 2, S. 145 – 154
-
Phäochromozytomatose nach Adrenalektomie : Metastasierung oder Zellverschleppung?In: Der Chirurg, Jg. 91, 2020, Nr. 4, S. 345 – 353
-
Überlebensvorteil für Primärtumorresektion hepatisch metastasierter gastrointestinaler neuroendokriner TumorenIn: Der Chirurg, Jg. 91, 2020, Nr. 6, S. 512DOI (Open Access)
-
Aktive Überwachung vs. primäre Chirurgie beim papillären Mikrokarzinom der SchilddrüseIn: Der Chirurg, Jg. 90, 2019, Nr. Suppl. 2, S. 110
-
Metastasierte neuroendokrine Dünndarmtumoren : Ileusprophylaktische OperationIn: Der Chirurg, Jg. 90, 2019, Nr. Suppl. 2, S. 102DOI (Open Access)
-
Platysmanaht zum Wundverschluss nach Thyreoidektomie?In: Der Chirurg, Jg. 90, 2019, Nr. 4, S. 323DOI (Open Access)
-
Surgery for adrenal angiomyelolipoma : an individualized conceptIn: Langenbeck's Archives of Surgery, Jg. 404, 2019, Nr. 4, S. 403 – 409
-
Value of ileus-prophylactic surgery for metastatic neuroendocrine midgut tumoursIn: Best Practice and Research Clinical Endocrinology and Metabolism, Jg. 33, 2019, Nr. 5, S. 101342
-
Anaplastic thyroid carcinoma : review of treatment protocolsIn: Endocrine-Related Cancer, Jg. 25, 2018, Nr. 3, S. R153 – R161DOI (Open Access)
-
Chirurgische Aspekte bei kleinen neuroendokrinen DünndarmtumorenIn: Der Chirurg, Jg. 89, 2018, Nr. 6, S. 428 – 433
-
Genotype-specific progression of hereditary medullary thyroid cancerIn: Human Mutation, Jg. 39, 2018, Nr. 6, S. 860 – 869
-
Geographic epidemiology of medullary thyroid cancer families : Unearthing European ancestral heritageIn: Endocrine-Related Cancer, Jg. 25, 2018, Nr. 4, S. L27 – L30DOI (Open Access)
-
Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutationsIn: British Journal of Surgery (BJS), Jg. 105, 2018, Nr. 2, S. e150 – e157
-
Metastasierte neuroendokrine Dünndarmtumoren : Ileusprophylaktische OperationIn: Der Chirurg, Jg. 89, 2018, Nr. 4, S. 310DOI (Open Access)
-
Neuroendokrine Neoplasien im deutschen NET-RegisterIn: Zeitschrift für Gastroenterologie, Jg. 56, 2018, Nr. 10, S. 1237 – 1246
-
The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2In: Endocrine-Related Cancer, Jg. 25, 2018, Nr. 2, S. E1 – E4DOI (Open Access)
-
Twenty-year experience of paediatric thyroid surgery using intraoperative nerve monitoringIn: British Journal of Surgery (BJS), Jg. 105, 2018, Nr. 8, S. 996 – 1005
-
Aktive Überwachung vs. primäre Chirurgie beim papillären Mikrokarzinom der SchilddrüseIn: Der Chirurg, Jg. 88, 2017, Nr. 1, S. 71 – 71
-
Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC.In: OncoTarget, Jg. 8, 2017, Nr. 7, S. 11950 – 11962DOI (Open Access)
-
Happy 20th anniversary MEN1 : from positional cloning to gene function restorationIn: Endocrine-Related Cancer, Jg. 24, 2017, Nr. 10, S. E7 – E11
-
Tissue-based quantitative proteome analysis of human hepatocellular carcinoma using tandem mass tagsIn: Biomarkers, Jg. 22, 2017, Nr. 2, S. 113 – 122
-
Bedeutung der Tumorgröße bei pankreatischen neuroendokrinen TumorenIn: Der Chirurg, Jg. 87, 2016, Nr. 12, S. 1077
-
Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infectionIn: Journal of Viral Hepatitis, Jg. 23, 2016, Nr. 5, S. 375 – 386
-
Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesionsIn: Journal of Clinical Pathology: JCP Online, Jg. 69, 2016, Nr. 7, S. 619 – 626
-
Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular CarcinomaIn: Journal of Proteome Research, Jg. 15, 2016, Nr. 1, S. 38 – 47
-
Quantitative proteome analysis reveals the correlation between endocytosis-associated proteins and hepatocellular carcinoma dedifferentiationIn: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Jg. 1864, 2016, Nr. 11, S. 1579 – 1585
-
A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumorsIn: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Jg. 1854, 2015, Nr. 6, S. 641 – 650
-
Analysis of disease-associated protein expression using quantitative proteomics : fibulin-5 is expressed in association with hepatic fibrosisIn: Journal of Proteome Research, Jg. 14, 2015, Nr. 5, S. 2278 – 2286
-
Differential proteomic and tissue expression analyses identify valuable diagnostic biomarkers of hepatocellular differentiation and hepatoid adenocarcinomasIn: Pathology, Jg. 47, 2015, Nr. 6, S. 543 – 550
-
TRAIL expression levels in human hepatocellular carcinoma have implications for tumor growth, recurrence and survivalIn: International Journal of Cancer, Jg. 136, 2015, Nr. 4, S. E154 – E160DOI (Open Access)
-
A practical data processing workflow for multi-OMICS projectsIn: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Jg. 1844, 2014, Nr. 1 Part A, S. 52 – 62DOI (Open Access)
-
IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinomaIn: Biomarkers in Medicine, Jg. 8, 2014, Nr. 5, S. 687 – 698
-
Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinomaIn: Molecular and Cellular Proteomics (MCP), Jg. 13, 2014, Nr. 10, S. 2661 – 2672
-
Lymphocytes and thyroid cancer : More to it than meets the eye?In: Endocrine-Related Cancer, Jg. 21, 2014, Nr. 3, S. C1 – C5DOI (Open Access)
-
Characteristics of pheochromocytoma patientsIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, S. 81
-
Clinical outcome of poorly differentiated (neuro)-endocrine carcinomas (NEC-G3) in a multi-center cohort from GermanyIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, S. P57
-
Fulminant progressive thyroid cyst with tracheal compression - a case reportIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, Nr. 3, S. P23
-
HCC development is supported by protesomal degradation of the tumor suppressor PMLIn: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S445
-
Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinomaIn: Translational Oncology, Jg. 6, 2013, Nr. 4, S. 420 – 428
-
Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics studyIn: Molecular and Cellular Proteomics (MCP), Jg. 12, 2013, Nr. 7, S. 2006 – 2020
-
Claudin-7 Expression in Hepatocellular CarcinomaIn: Transplantation Proceedings, Jg. 44, 2012, Nr. 9, S. 2737 – 2740
-
Genetic Background May Confer Susceptibility to PTC in Benign Multinodular Thyroid DiseaseIn: Journal of Cancer Therapy (JCT), Jg. 3, 2012, S. 997 – 1001DOI (Open Access)
-
Personalized medicine : Caught between hope, hype and the real worldIn: Clinics, Jg. 67, 2012, Nr. S1, S. 91 – 97
-
Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue-influence of a modulated host stroma on the prognosis of HCCIn: Langenbeck's Archives of Surgery, Jg. 395, 2010, Nr. 4, S. 395 – 405
-
Donor origin de novo HCC in a noncirrhotic liver allograft 3 years after liver transplantation : Letter to the editorIn: Transplant International, Jg. 23, 2010, Nr. 3, S. 341 – 343
-
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasionIn: Molecular Cancer, Jg. 9, 2010, 227DOI (Open Access)
-
Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resectionIn: Journal of Gastrointestinal Surgery, Jg. 13, 2009, Nr. 9, S. 1583 – 1592
-
Liver Transplantation for Hepatocellular Carcinoma : University Hospital Essen Experience and Metaanalysis of Prognostic FactorsIn: Journal of the American College of Surgeons, Jg. 205, 2007, Nr. 5, S. 661 – 675
-
Liver transplantation for patients with metastatic endocrine tumors : Single-center experience with 15 patientsIn: Liver Transplantation, Jg. 12, 2006, Nr. 7, S. 1089 – 1096DOI (Open Access)
-
Schilddrüsenkarzinome im WandelIn: Der Chirurg. Berlin: Springer, Jg. 91, 2020, Nr. 12, S. 991 – 993DOI (Open Access)
-
Abdominelle Manifestationen mikrobieller und parasitärer SystemerkrankungenIn: Der Chirurg. Berlin: Springer, Jg. 90, 2019, Nr. 10, S. 816 – 817DOI (Open Access)
-
Modern endocrine surgery – Striving for a better quality of lifeIn: Best Practice and Research Clinical Endocrinology and Metabolism: Elsevier, Jg. 33, 2019, Nr. 5, S. 101343
-
Frühkarzinome endokriner OrganeIn: Der Chirurg. Berlin: Springer, Jg. 89, 2018, Nr. 6, S. 413 – 414DOI (Open Access)
-
A novel variant in PRKAR1A at the exon-intron border leads to aberrant splicing in patients affected by carney complex
61st Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 21–23, 2023, The Hague, The Netherlands,In: Hormone Research in Paediatrics. Basel: Karger, Jg. 96, 2023, Nr. Suppl. 4, S. 449 – 450DOI (Open Access) -
Presence of circulating tumor cells with stem cell characteristics predicts response to SIRT in hepatocellular carcinoma
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 53 -
Sex Hormone Binding Globulin Is Deregulated in Aggressive Hepatocellular Carcinoma and Predicts Early Tumor Recurrence
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 50 -
A novel method for the detection of different subgroups of circulating tumor cells in patients with hepatocellular carcinoma
63rd Annual Meeting of the American Association for the Study of Liver Diseases, The Liver Meeting 2012, November 9-13, 2012, Boston, Mass., USA,In: Hepatology. Hoboken: Wiley & Sons, Jg. 56, 2012, Nr. Suppl. 1, S. 457A -
862 Decreased expression of MIR-199a-5p contributes to increased cell invasion by functional deregulation of DDR1 activity in hepatocellular carcinoma
45th annual meeting of the European Association for the Study of the Liver (EASL) 14-18 April 2010 • Vienna, Austria,In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 52, 2010, Nr. Suppl. 1, S. S336 -
Combined medical therapy, nuclear medicine therapy and other therapies in metastatic neuroendocrine tumorIn: Nuclear Medicine and Molecular Imaging: Volume 4: Nuclear Medicine Therapy / Signore, Alberto / Sathekge, Mike; Luster, Markus (Hrsg.). Amsterdam: Elsevier, 2022, S. 145 – 156
-
Hemithyroidectomy with en bloc Ipsilateral Central Node Dissection for Low-Risk Papillary and Medullary Thyroid CancerIn: Atlas of Thyroid Surgery / Shifrin, Alexander. Cham: Springer International Publishing, 2022, S. 129 – 142